This is a poster presentation by Oncosec on 9/9 at the "First World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food & Environmental Technologies". Looks like they are really progressing with an INTERNAL electroporation device. SWEET!!!
Nothing going for it at the present time??? How about four Phase 2 trials you idiot!
Sour grapes Sal? Nice timing on shorting ONCS yesterday...LOL! And by the way, first evaluation is 12 weeks after dosing, so we will get interim data this year. 24-36 months??? Ha....nice try shorty!
Sorry biotrader, but I don't believe this is NVIV's patient #4. If you go to Yara's Foundation website, you will see that this person had his injury & procedure done in May 2014 by Neuralstem.
It is a validation of electroporation AND the use of IL-12, as the deal centers around INO-3112, which is INO's VGX-3100 vaccine with IL-12. This is a big deal for ONCS as well, it shows that ONCS and Dr.Pierce are on the right track with ImmunoPulse.
They will have to PAY patients to get enrolled??? Are you freakin' serious??? The combo trial is for patients who are running out of time and options. 70% of patients who have taken Keytuda as a monotherapy DO NOT RESPOND. ONCS is trying to help those people. Not to mention that these patients are getting Keytruda for FREE! You really know NOTHING about this trial.
I am happy for them...that is great news for these people. However, a couple of questions come to mind...
1. Can they just stand and not move their legs (unlike J&J who can)?
2. Do they have any B&B improvement (which J&J do have)?
If the answer is no to these questions, there is NO comparison.
Sal, you really are quite annoying. You hate the company, you hate the CEO, you sold your shares.....move on already!! You are being extremely immature!